İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

Quantitative Iron Measurements in the Basal Ganglia of NBIA Patients Using QSM : Insights From a Tertiary Center

Annals of Clinical and Translational Neurology

YÖKSİS OpenAlex ISSN 2328-9503 DOI 10.1002/acn3.70161 Atıf 3 Açık erişim · gold SJR Q1 JCR Q2

10.1002/acn3.70161

YÖKSİS YÖKSİS makale kaydı

OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex kaydı

İngilizce (OpenAlex)

OBJECTIVE: Neurodegeneration with brain iron accumulation (NBIA) comprises rare genetic disorders characterized by predominantly extrapyramidal symptoms and iron deposition in the basal ganglia. Conventional magnetic resonance imaging (MRI) detects qualitative changes but cannot accurately quantify iron accumulation. Quantitative susceptibility mapping (QSM) allows precise in vivo quantification of iron, providing insight into the pathophysiology of the disease. METHODS: We studied 27 genetically confirmed NBIA patients and 11 age-matched healthy controls using susceptibility-weighted imaging (SWI) on a 3 Tesla MRI scanner. Basal ganglia regions of interest (ROIs) were manually delineated and QSM values were extracted. RESULTS: Sixteen NBIA patients and 11 controls were analyzed. QSM showed significantly higher iron in the globus pallidus (GP) (p = 0.008), with PKAN patients showing a 2.5-fold increase in GP iron (p = 0.001). MPAN patients showed 2.5 times higher iron in both GP and substantia nigra (SN). A GP iron level > 0.1133 ppm increased the likelihood of PKAN 18-fold. Atypical PKAN cases had 2.5 times higher SN iron levels compared to classic cases. INTERPRETATION: QSM is a sensitive and noninvasive tool for detecting and quantifying iron accumulation in NBIA. The GP consistently showed the highest susceptibility values across subtypes, emphasizing its significant role in disease pathology. Distinct patterns of iron deposition in different NBIA subtypes may reflect subtype-specific mechanisms with diagnostic and therapeutic relevance. Age-related susceptibility changes were found to be significant, reinforcing the need to account for age when interpreting QSM data. More importantly, QSM may serve as a candidate biomarker for longitudinal disease monitoring in future clinical trials targeting disease-modifying therapies in NBIA.

OpenAlex zenginleştirmesi

Konular

  • Neurological diseases and metabolism
  • Neurological and metabolic disorders
  • Neurological disorders and treatments

Tür: article Neurological diseases and metabolism

İndeks bilgisi

WoS (JCR) ve Scopus (SJR) çeyrekleri ISSN ve yayın yılına göre. · 2025

Scopus (SJR) / WoS (JCR)

Annals of Clinical and Translational Neurology

Scopus (SJR) Q1 1,645 2025 yılı
WoS (JCR) Q2 JIF 3,9 2025 yılı

Üniversiteler

  • İSTANBUL TEKNİK ÜNİVERSİTESİ

Yazarlar

  1. ÖZGE UYGUN
  2. İBRAHİM ALPAY ÖZCAN
  3. Fuat Kaan Aras
  4. Evrim Bozdemir
  5. Sibel Uğur İşeri
  6. KORAY KIRIMTAY
  7. ARZU KARABAY KORKMAZ İSTANBUL TEKNİK ÜNİVERSİTESİ
  8. MURAT GÜLTEKİN
  9. NİHAN HANDE AKÇAKAYA
  10. Orkhan Mammadov
  11. GÜLAY KIR
  12. Dilek İnce Günal
  13. EMİNE NEŞE TUNCER
  14. FATMA BETÜL ÖZDİLEK
  15. BANU ÖZEN BARUT
  16. ERCAN KÖSE
  17. HÜLYA APAYDIN
  18. Asuman Ali
  19. Sultan Çağırıcı
  20. PINAR TOPALOĞLU
  21. ALP DİNÇER
  22. ZÜHAL YAPICI OBUZ